Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (31-40 of 333) with videos related to

Pageof 34
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosisThomas F Scott, Carol J Schramke, Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
The MS Co-Operative REsearch (MS-CORE) group: an alternate approach to fostering multicenter studiesJeff Cohen, Gary Cutter, Fred Lublin, et al.
JAMA|October 25, 2012
Treatment with interferon beta for multiple sclerosisDouglas S Goodin, Anthony T Reder, Gary Cutter
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
Caution in interpreting disease-modification claims with lecanemab: Selective reporting and causal inferenceLon S Schneider, Richard E Kennedy, Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2019
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data setsMarcus W Koch, Jop Mostert, Bernard Uitdehaag, et al.
Muscle & Nerve|September 4, 2019
Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysisLinda Harris, Inmaculada B Aban, Haichang Xin, et al.
Journal of Clinical Neuromuscular Disease|August 25, 2020
Longitudinal Analysis of Disease Burden in Refractory and Nonrefractory Generalized Myasthenia Gravis in the United StatesLinda Harris, Phillip H Allman, Reinee Sheffield, et al.
Neurology|December 3, 2011
Evidence-based guideline update: plasmapheresis in neurologic disordersHenry Kaminski, Gary Cutter, Robert L Ruff, et al.
Annals of Clinical and Translational Neurology|April 17, 2025
Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should careJustin M Leach, Inmaculada Aban, Gary Cutter, et al.
Neurology|October 28, 2009
A cross-sectional study of bone health in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
Pageof 34

Showing results (31-40 of 333) with videos related to

Sort By:
Pageof 34
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 20, 2003
Sample size estimates for determining treatment effects in high-risk patients with early relapsing-remitting multiple sclerosisThomas F Scott, Carol J Schramke, Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 30, 2004
The MS Co-Operative REsearch (MS-CORE) group: an alternate approach to fostering multicenter studiesJeff Cohen, Gary Cutter, Fred Lublin, et al.
JAMA|October 25, 2012
Treatment with interferon beta for multiple sclerosisDouglas S Goodin, Anthony T Reder, Gary Cutter
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 21, 2026
Caution in interpreting disease-modification claims with lecanemab: Selective reporting and causal inferenceLon S Schneider, Richard E Kennedy, Gary Cutter
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 14, 2019
Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data setsMarcus W Koch, Jop Mostert, Bernard Uitdehaag, et al.
Muscle & Nerve|September 4, 2019
Employment in refractory myasthenia gravis: A Myasthenia Gravis Foundation of America Registry analysisLinda Harris, Inmaculada B Aban, Haichang Xin, et al.
Journal of Clinical Neuromuscular Disease|August 25, 2020
Longitudinal Analysis of Disease Burden in Refractory and Nonrefractory Generalized Myasthenia Gravis in the United StatesLinda Harris, Phillip H Allman, Reinee Sheffield, et al.
Neurology|December 3, 2011
Evidence-based guideline update: plasmapheresis in neurologic disordersHenry Kaminski, Gary Cutter, Robert L Ruff, et al.
Annals of Clinical and Translational Neurology|April 17, 2025
Handling rescue therapy in myasthenia gravis clinical trials: why it matters and why you should careJustin M Leach, Inmaculada Aban, Gary Cutter, et al.
Neurology|October 28, 2009
A cross-sectional study of bone health in multiple sclerosisRuth Ann Marrie, Gary Cutter, Tuula Tyry, et al.
Pageof 34